{{Rsnum
|rsid=902774
|Chromosome=12
|position=52880120
|Orientation=plus
|GMAF=0.09642
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 4.4 | 19.5 | 76.1
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.9 | 5.3 | 93.8
| YRI | 0.0 | 15.1 | 84.9
| ASW | 0.0 | 14.3 | 85.7
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.9 | 99.1
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.9 | 13.6 | 85.5
| MEX | 0.0 | 32.1 | 67.9
| MKK | 0.0 | 7.7 | 92.3
| TSI | 2.0 | 30.4 | 67.6
| HapMapRevision=28
}}{{Report GE
|PubMed=18264097
|Source=journal
|AffyProbeset=SNP_A-8629651
|AffyOrientation=reverse
|AlleleA=C
|AlleleB=T
|onGW5=0
|rsid=902774
|ancestral=G
|RiskPopulation=UK, Australia
|RiskAllele=A
|CaseFreq=0.18
|ControlFreq=0.14
|OddsRatioHet=1.34
|OddsRatioHom=2.29
|OddsRatioAll=
|Disease=Prostate cancer
|DiseaseSymbol=PC
}}

rs902774 increases susceptibility to Prostate cancer 1.34 times for heterozygotes (AG) and 2.29 times for homozygotes (AA) {{PMID|18264097}}

{{PMID Auto GWAS
|PMID=21743057
|Trait=None
|Title=Genome-wide association study identifies new prostate cancer susceptibility loci.
|RiskAllele=A
|Pval=5E-9
|OR=1.1700
|ORtxt=[1.11-1.24]
|OA=1
}}

{{PMID|19639606|OA=1
}} Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases.

{{PMID Auto
|PMID=23405784
|Title=[Susceptibility to prostate cancer in Han Chinese: single nucleotide polymorphism analysis of 1 667 cases]
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}